Cc. Dykstra et al., SELECTIVE-INHIBITION OF TOPOISOMERASES FROM PNEUMOCYSTIS-CARINII COMPARED WITH THAT OF TOPOISOMERASES FROM MAMMALIAN-CELLS, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 1890-1898
Type I and II topoisomerase activities were partially purified from Pn
eumocystis carinii. The catalytic (strand-passing) activities of both
enzymes were selectively inhibited by members of a series of dicationi
c-substituted bis-benzimidazoles compared with those of topoisomerases
of mammalian (calf thymus) origin. The most active inhibitors of the
parasite enzymes were also highly effective in an in vivo animal model
of P. carinii pneumonia. Selected dicationic-substituted bis-benzimid
azoles also strongly inhibited the induction of the topoisomerase I- a
nd II-mediated cleavable complex, suggesting that the biologically act
ive DNA minor groove-binding molecules inhibit the enzyme-DNA binding
step of the topoisomerase reaction sequence. The apparent selectivitie
s for the parasite enzymes and the low levels of toxicity to mammalian
cells for the biologically active bis-benzimidazoles suggest that the
se compounds hold promise as effective therapeutic agents in the treat
ment of a life-threatening AIDS-related disease, P. carinii pneumonia.